"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

US workers facing high economic hardship, especially those in lower-wage occupations, were significantly more likely to ...

Findings offer a potential basis for sex-specific dietary guidelines for metabolic dysfunction–associated steatotic liver ...

Stem cell transplants could produce promising remission rates for children with severe monogenic inflammatory bowel disease ...

Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...

Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...

Panelists discuss how to overcome barriers to comprehensive molecular testing and how to prioritize treatment when ALK+ ...

Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; ...

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.